In a mouse model of colitis-associated fibrosis, treatment with anti-IL-17 antibodies reduced fibrosis markers like collagen III, TIMP-1, and MMP-2, as well as pro-fibrotic cytokines IL-1β, TGF-β1, and TNF-α [157]. The gene discussed is TGFB1; the disease is colitis.